DWS: The prediction for the number of interest rate cuts by the Federal Reserve before the end of next year has been lowered to 3 times.
DWS has lowered its predictions for interest rate cuts by the end of 2025 from 5 times to 3 times (including one in December).
DWS Chief US Economist Christian Scherrmann stated that recent economic data in the United States has been mixed, with the labor market appearing to trend towards weakness while inflation remains stubborn. Despite this, DWS believes that progress has been made in controlling inflation and there is still a chance for further interest rate cuts. DWS has revised its forecast for rate cuts before the end of 2025 from 5 to 3 (including one in December) and expects the central bank to slow down the pace of rate cuts after the December meeting. In terms of timing, the bank anticipates that the Federal Reserve may switch to adjusting rates quarterly in the first half of 2025 and then pause the normalization of interest rate policy in the second half of the year.
Additionally, DWS stated that future fiscal and trade policies remain major unknown factors. Federal Reserve Chairman Powell explicitly stated in the last meeting not to make excessive assumptions or expectations, but DWS believes that at least the extension of provisions from the "Tax Cuts and Jobs Act" should be included in future outlook considerations. Unlike other policy proposals (such as tax cuts, tariffs, or immigration), lawmakers seem to have reached a consensus on extending existing stimulus measures. As a result, households and businesses may anticipate stronger domestic demand, leading to increased hiring or sustaining current levels of consumption.
DWS believes that the Federal Reserve will signal the need for more time to lower rates to neutral levels (expected to be between 3 and 3.5%). Therefore, the bank expects that the upcoming economic forecast summary will show continued strong economic growth in 2025, but with fewer rate cuts and slight inflation increase.
Related Articles

US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.

US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.

The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.
US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.

US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.

The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


